Dec 12, 2023 Cellectar Biosciences Strengthens Intellectual Property Protection for its PDC Platform Learn More
Dec 5, 2023 Cellectar Biosciences to Present at the Targeted Radiopharmaceuticals Summit Europe Learn More
Nov 2, 2023 Cellectar to Release Top-line Data from WM Pivotal Trial During the JP Morgan Healthcare Conference the Week of January 8, 2024 Learn More
Oct 25, 2023 Cellectar Biosciences Partners with Florida Cancer Specialists & Research Institute to Support the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting Learn More